VanEck Biotech ETF Rating $165.41 -0.10 (-0.06%) Closing price 03:58 PM EasternExtended Trading$165.00 -0.41 (-0.25%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.68Holdings in BBH have an aggregate rating of Moderate Buy based on 488 analyst ratings issued in the past year covering 24 companies (100.0% of the portfolio).BBH Aggregate Price Target$165.41High Prediction$165.41Average Prediction$165.41Low Prediction$165.41Holdings in BBH have an aggregate price target of $165.41 and a range of $165.41 to $165.41 covering 24 companies (100.0% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings15.35%AMGNAmgen$287.97-0.6%4.7471 of 5 stars2.33$304.43 5.7%21Positive NewsAnalyst Forecast12.84%GILDGilead Sciences$113.92-0.7%4.9859 of 5 stars2.88$115.39 1.3%26Trending News8.69%VRTXVertex Pharmaceuticals$389.08+0.5%4.9435 of 5 stars2.56$497.10 27.8%27Positive News6.54%ALNYAlnylam Pharmaceuticals$454.18+0.7%4.0548 of 5 stars2.85$405.33 -10.8%265.36%ARGXargenex$707.960.0%3.279 of 5 stars3.10$763.47 7.8%21Trending NewsAnalyst ForecastAnalyst Revision5.35%REGNRegeneron Pharmaceuticals$586.96-0.1%4.8566 of 5 stars2.81$817.67 39.3%27Trending NewsAnalyst Forecast4.87%IQVIQVIA$188.82+0.6%4.9026 of 5 stars2.74$228.62 21.1%23Positive News4.41%INSMInsmed$134.53+1.8%3.7704 of 5 stars2.94$132.57 -1.5%174.06%NTRANatera$163.04-1.6%3.1194 of 5 stars3.06$193.19 18.5%18Positive News3.56%ICLRIcon$174.00+1.3%4.6229 of 5 stars2.75$218.38 25.5%163.50%BIIBBiogen$136.36-0.3%4.809 of 5 stars2.34$185.74 36.2%32Positive News3.24%ONCBeOne Medicines$300.14-2.8%1.413 of 5 stars3.00$330.89 10.2%72.87%ILMNIllumina$99.54+0.8%4.8699 of 5 stars2.25$124.58 25.2%20Positive News2.84%BNTXBioNTech$103.01-1.7%2.6696 of 5 stars2.76$135.80 31.8%172.82%NBIXNeurocrine Biosciences$138.13+0.9%4.8625 of 5 stars2.86$159.50 15.5%21News CoveragePositive News2.41%INCYIncyte$84.84+1.0%4.6678 of 5 stars2.33$81.60 -3.8%182.05%MRNAModerna$25.10+1.5%4.4987 of 5 stars2.04$42.88 70.8%241.71%TECHBio-Techne$56.22-1.0%4.8461 of 5 stars2.69$69.42 23.5%13Positive News1.63%QGENQiagen$48.00-1.8%4.0132 of 5 stars2.27$49.69 3.5%11News Coverage1.51%CRLCharles River Laboratories International$162.66-0.6%4.1639 of 5 stars2.27$175.69 8.0%15Positive News1.48%BMRNBioMarin Pharmaceutical$58.66+2.1%4.9963 of 5 stars2.72$93.17 58.8%25Positive News1.27%EXASExact Sciences$46.71+1.3%4.9353 of 5 stars2.91$67.05 43.5%23Positive News1.23%RGENRepligen$118.88-1.3%4.8595 of 5 stars2.73$169.45 42.5%11Positive News0.38%SRPTSarepta Therapeutics$18.07-1.0%4.5593 of 5 stars2.07$43.50 140.7%29Analyst Forecast This page (NASDAQ:BBH) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access